Literature DB >> 8448653

Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus.

D P Figlewicz1, P Szot, P A Israel, C Payne, D M Dorsa.   

Abstract

Acute and chronic in vitro insulin treatment can inhibit the uptake of norepinephrine (NE) by adult rat brain synaptosomes and slices, fetal neuronal cultures, and PC12 cells. In the present study we tested whether chronic in vivo insulin treatment could alter the biosynthetic capacity of rat locus coeruleus neurons for the NE transporter protein (NET). Chronic third ventricular insulin treatment resulted in a suppression of NET mRNA to about one third of the level of vehicle-treated controls. Our finding suggests that insulin may play a regulatory role in the synthesis of this transporter, thereby modulating activity in CNS noradrenergic pathways.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448653     DOI: 10.1016/0006-8993(93)90258-o

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  29 in total

Review 1.  Insulin signaling and addiction.

Authors:  Lynette C Daws; Malcolm J Avison; Sabrina D Robertson; Kevin D Niswender; Aurelio Galli; Christine Saunders
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

Review 2.  The association of diabetes and dementia and possible implications for nondiabetic populations.

Authors:  Ramit Ravona-Springer; Michal Schnaider-Beeri
Journal:  Expert Rev Neurother       Date:  2011-11       Impact factor: 4.618

Review 3.  The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes.

Authors:  K P Lesch; A Heils; P Riederer
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

Review 4.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

Review 5.  Insulin, cognition, and dementia.

Authors:  Brenna Cholerton; Laura D Baker; Suzanne Craft
Journal:  Eur J Pharmacol       Date:  2013-09-23       Impact factor: 4.432

6.  No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia.

Authors:  Xiaoduo Fan; Emily Liu; Oliver Freudenreich; Paul Copeland; Douglas Hayden; Musie Ghebremichael; Bruce Cohen; Dost Ongur; Donald C Goff; David C Henderson
Journal:  J Clin Psychopharmacol       Date:  2013-04       Impact factor: 3.153

Review 7.  Deregulation of brain insulin signaling in Alzheimer's disease.

Authors:  Yanxing Chen; Yanqiu Deng; Baorong Zhang; Cheng-Xin Gong
Journal:  Neurosci Bull       Date:  2014-03-20       Impact factor: 5.203

8.  Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice.

Authors:  Michael A Siuta; Sabrina D Robertson; Heidi Kocalis; Christine Saunders; Paul J Gresch; Vivek Khatri; Chiyo Shiota; J Philip Kennedy; Craig W Lindsley; Lynette C Daws; Daniel B Polley; Jeremy Veenstra-Vanderweele; Gregg D Stanwood; Mark A Magnuson; Kevin D Niswender; Aurelio Galli
Journal:  PLoS Biol       Date:  2010-06-08       Impact factor: 8.029

Review 9.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

10.  The role of endoplasmic reticulum stress in hippocampal insulin resistance.

Authors:  Catrina Sims-Robinson; Anna Bakeman; Rebecca Glasser; Janet Boggs; Crystal Pacut; Eva L Feldman
Journal:  Exp Neurol       Date:  2016-01-13       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.